首页> 外国专利> PERTUSSIS TOXIN MUTANTS, BORDETELLA STRAINS CAPABLE OF PRODUCING SUCH MUTANTS AND THEIR USE IN THE DEVELOPMENT OF ANTIPERTUSSIS VACCINES

PERTUSSIS TOXIN MUTANTS, BORDETELLA STRAINS CAPABLE OF PRODUCING SUCH MUTANTS AND THEIR USE IN THE DEVELOPMENT OF ANTIPERTUSSIS VACCINES

机译:百日咳毒素突变株,能产生此类突变株的波尔多菌株及其在抗菌肽疫苗开发中的用途

摘要

New pertussis toxin (PT) mutants are described being immunologicallyactive and having reduced or no toxicity, characterized in that atleast one of the aminoacid residues G1u129, Asp11, Trp26, Arg9,Phe50, Asp1, Arg13, Tyr130, Gly86, Ile88, Tyr89, Tyr8, Gly 44, Thr53and G1y80 of subunit's 1 aminoacid sequence is deleted andsubstituted by a different aminoacid residue selected in the groupof natural aminoacids; Bordetella strains capable of providing andsecreting said PT mutants and means and methods for obtaining themare also described.The Bordetella strains and the PT mutants produced by them areparticularly suitable for the preparation of effective cellular andacellular antipertussis vaccines.
机译:新的百日咳毒素(PT)突变体被描述为具有免疫学意义活性且毒性降低或无毒性,其特征在于氨基酸残基G1u129,Asp11,Trp26,Arg9中的至少一个,Phe50,Asp1,Arg13,Tyr130,Gly86,Ile88,Tyr89,Tyr8,Gly 44,Thr53删除亚基1个氨基酸序列的G1y80,被选自组中的另一个氨基酸残基取代天然氨基酸;能够提供和分泌所述PT突变体以及获得它们的手段和方法也有描述。由它们产生的博德特氏菌菌株和PT突变体是特别适合于制备有效的细胞和无细胞百日咳疫苗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号